查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495950

鼻腔包装设备市场－2024年至2029年预测

Nasal Packaging Devices Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

鼻腔包装设备市场预计将从2022年的178,456,000美元成长到2029年的250,677,000美元，复合年增长率为4.97%。

鼻包装装置是医疗设备，旨在在各种手术后在鼻腔内提供支撑、控制出血并防止粘连（组织粘在一起）。这些装置通常在鼻部组织脆弱且容易出血的手术后使用，例如鼻中隔重建、鼻窦和鼻窦手术。

鼻部问题盛行率的上升和意识的提高以及手术数量的增加是鼻部包装设备市场的主要成长动力。此外，老年人口的迅速增加以及包装技术的开拓预计将加速市场扩张。

市场驱动因素

  • 鼻部疾病发生率增加

随着慢性鼻窦、鼻中隔偏曲和鼻部外伤等鼻部疾病的盛行率持续上升，对鼻部包装装置的需求将会增加，以在手术后或作为治疗计划的一部分来控制这些疾病。

例如，仅在美国，鼻窦每年就影响约 3,000 万人。据鼻窦和过敏健康中心称，鼻窦感染造成数十亿美元的经济损失和数百万工作日的损失。此外，鼻窦每年导致约 7,300 万天的活动受限。根据梅奥诊所的数据，大约 70% 至 80% 的人有鼻中隔明显偏曲的情况。

  • 外科手术呈上升趋势

世界范围内，包括鼻整形术、鼻中隔重建和鼻窦手术在内的鼻部手术数量正在增加。这些手术通常需要鼻包装装置来控制出血、促进癒合并达到最佳手术效果。

例如，密西根大学耳鼻喉科每年进行近 500 例鼻腔手术，接待约 1,600 万名患者。此外，UT 西南耳鼻喉科每年进行约 700 例功能性内视镜鼻窦手术。

  • 先进封装技术

技术创新促进了更有效、更适合患者的鼻部包装设备的开发。这些进步包括生物相容性材料的使用、改进的设计和侵入性较小的插入技术。

鼻腔包装装置使用生物相容性材料，如医用级硅胶、水凝胶和可吸收聚合物，以最大限度地减少组织刺激，降低过敏反应的风险，并促进更好的癒合。 3D 列印技术的进步使得可以根据每位患者的鼻部解剖结构创建个人化的鼻部包装装置。这提供了更好的贴合性并改善术后结果。

此外，一些鼻腔包装装置具有药物释放型功能，可将药物和治疗剂直接释放到鼻腔中，以促进癒合、减少发炎和预防感染。

  • 老化

在人口老化中，更容易出现与鼻子和鼻窦相关的问题。随着世界人口持续老化，对鼻腔手术及相关设备的需求将会增加，这很可能会刺激鼻腔包装设备市场。老年鼻炎患者可能会出现鼻塞或鼻塞、流鼻水过多、鼻子发痒、打喷嚏、鼻道干燥和结痂等症状。

例如，根据世界卫生组织的数据，2015年至2050年间，全球60岁及以上老年人的比例将从12%增加到22%。

  • 意识和教育

随着患者和医疗保健专业人员对适当术后护理益处的认识不断提高，鼻腔包装设备市场可能会成长。为此，我们正在做出一些努力。

例如，2021 年 3 月，亨利·福特医师发起了一项全球倡议，旨在加强全球耳鼻喉科医生和牙科专业人员之间的跨学科合作，以检测牙源性鼻窦(ODS)。此外，每年，美国耳鼻喉头颈外科学会 (AAO-HNS) 都会支持表彰世界鼻窦健康意识日。

2022 年，这项赞助是与美国鼻科学会以及企业合作伙伴美敦力 (Medtronic) 合作实施的。

市场限制因素：

儘管鼻腔包装设备市场正在经历成长和开拓，但一些限制和挑战可能会影响市场的扩张。例如，使用尖端材料和技术开发和製造先进的鼻包装装置可能会导致製造成本增加。

这些成本可能会影响患者和医疗保健提供者的定价和可及性。使用一次性鼻腔包装装置会产生医疗废弃物。随着永续性变得更加重要，开发环保包装解决方案可能变得必要。

北美地区预计将大幅成长

预计在预测期内，北美将占据鼻腔包装设备市场的重要份额。

这一份额是由于越来越多地使用鼻腔填塞设备来解决因鼻腔和鼻窦疾病增加而导致的流鼻血患者数量的增加，以及越来越多的参与企业该地区的市场，以下是我们正在做的一些事。例如，根据密西根大学卫生部门的数据，慢性鼻窦影响美国约 3,100 万人。

主要市场参与企业

  • Anthony Products 是一家专门为包括耳鼻喉科在内的各种医疗领域製造和供应医疗设备、设备和设备的公司。我们有鼻垫片、30秒Psyrocket鼻贴等。
  • Innovia Medical 成立于 1978 年，是一家专注于化妆品、耳鼻喉等各个领域的外科公司。该公司提供 Absorbent® 解剖鼻包用于流鼻血管理。
  • Nipro 是一家日本医疗设备製造商，成立于 1954 年。该公司的 Exadose(TM) 鼻喷剂采用新颖的两步骤计量剂量方法。独特的柱塞设计可以精确地将半剂量注射到每个鼻腔中。

新兴市场的主要发展

  • 2023年7月，FDA核准Harm Reduction Therapeutics公司开发的RiVive™非鼻喷雾作为阿片类药物过量摄取的紧急治疗方法。
  • 2022 年 11 月，药物输送和活性物质科学解决方案领域的佼佼者 Aptar Pharma 是一家临床阶段生物製药公司，专门利用取得专利的薄膜冷冻技术平台开发和商业化创新药物，宣布与 TFF 建立合作伙伴关係。製药公司此次合作的重点是开发和评估干粉疫苗递送方法，该方法将 TFF Pharmaceutical 的薄膜冷冻技术与 Aptar Pharma 专有的鼻单剂量 (UDS) 粉末鼻喷雾系统相结合。
  • 2020 年 12 月，美敦力推出 Novapak鼻窦填塞和支架，这是专为鼻窦手术后使用而设计的一次性可溶解填塞物。它有助于控制出血，防止粘连，为患者的早期康復创造一个湿润的癒合环境。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行概述

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章鼻包装设备市场：副产品

  • 介绍
  • 注射
  • 凝胶
  • 喷
  • 敷料

第六章鼻包装设备市场：依类型

  • 介绍
  • 生物可吸收的
  • 不可吸收

第七章鼻包装设备市场：依最终用户分类

  • 介绍
  • 医院
  • 诊所
  • 其他的

第八章鼻包装设备市场：按地区

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 有竞争力的仪表板

第十章 公司简介

  • Meril Life
  • Anthony Products
  • Medtronic
  • Entsho
  • Innovia Medical
  • Cenefom
  • Nipro
  • Lohmann & Rauscher
  • Medline
简介目录
Product Code: KSI061616031

The nasal packaging devices market is expected to grow at a CAGR of 4.97% from US$178.456 million in 2022 to US$250.677 million in 2029.

Nasal packaging devices are medical devices designed to provide support, control bleeding, and prevent adhesions (tissue sticking together) in the nasal cavity after various procedures. These devices are often used following nasal surgeries, such as septoplasty, rhinoplasty, or sinus surgery, where the nasal tissues can be delicate and prone to bleeding.

The rising prevalence of nasal problems coupled with increasing awareness and more surgeries are major growth drivers of the nasal packaging devices market. Moreover, the rapidly growing elderly population along with the technological developments in packaging is further contemplated to accelerate the market expansion.

MARKET DRIVERS:

  • Rising Incidence of Nasal Conditions

As the prevalence of nasal conditions such as chronic sinusitis, deviated septum, and nasal trauma continues to rise, the demand for nasal packaging devices to manage these conditions post-surgery or as part of treatment plans increases.

For instance, sinusitis affects around 30 million persons in the United States alone each year. It has an economic effect of billions of dollars and millions of days of missed work time according to the Sinus & Allergy Wellness Centre. Moreover, sinusitis accounts for roughly 73 million restricted activity days each year. Around 70 to 80 percent of individuals exhibit a noticeable deviation of the nasal septum according to a Mayo Clinic.

  • Growing Number of Surgical Procedures

The number of nasal surgeries, including rhinoplasty, septoplasty, and sinus surgeries, is on the rise globally. These procedures often require nasal packaging devices to control bleeding, promote healing, and ensure optimal surgical outcomes.

For instance, the otolaryngology Department of the University of Michigan Health performs nearly 500 nasal surgical interventions and around 16 million patients visit in a year. Additionally, around 700 functional endoscopic sinus surgery procedures are done at UT Southwestern each year as per the statement of M.D. Professor of Otolaryngology.

  • Advancements in Packaging Technology

Technological innovations have led to the development of more effective and patient-friendly nasal packaging devices. These advancements include the use of biocompatible materials, improved designs, and less invasive insertion techniques.

The use of biocompatible materials, such as medical-grade silicone, hydrogels, and absorbable polymers, in nasal packaging devices minimizes tissue irritation, reduces the risk of allergic reactions, and promotes better healing. Advancements in 3D printing technology allow for the creation of personalized nasal packaging devices tailored to individual patients' nasal anatomy. This promotes a better fit and improved post-operative outcomes.

Additionally, some nasal packaging devices incorporate drug-eluting capabilities, releasing medications or therapeutic agents directly into the nasal cavity to enhance healing, reduce inflammation, and prevent infection.

  • Aging Population

The aging population is more prone to nasal and sinus-related issues. As the global population continues to age, the demand for nasal surgeries and associated devices is likely to increase thereby stimulating the nasal packaging devices market. Individuals experiencing geriatric rhinitis might encounter symptoms such as blocked or congested nasal passages, excessive nasal discharge, itching in the nose, sneezing, as well as dryness or the formation of crusts within the nasal passages.

For instance, the percentage of people aged over 60 years worldwide will increase from 12% to 22% between 2015 and 2050 according to the WHO.

  • Increasing Awareness and Education

As awareness among patients and healthcare professionals about the benefits of proper post-operative care increases, the nasal packaging devices market is likely to grow. Several initiatives are being undertaken in this aim.

For instance, in March 2021, a Henry Ford physician launched a worldwide study effort to increase interdisciplinary collaboration between otolaryngologists and dental professionals throughout the world for detecting odontogenic sinusitis (ODS). Moreover, Annually, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) endorses the recognition of World Sinus Health Awareness Day.

In 2022, this sponsorship was carried out in partnership with the American Rhinologic Society and in collaboration with the corporate partner Medtronic.

MARKET RESTRAINTS:

The nasal packaging devices market has experienced growth and development however some restraints or challenges can impact its expansion. For example, developing and manufacturing advanced nasal packaging devices with cutting-edge materials and technologies can lead to higher production costs.

These costs can subsequently impact pricing and accessibility for patients and healthcare providers. The use of disposable nasal packaging devices can contribute to medical waste. As sustainability becomes a more significant concern, there may be pressure to develop environmentally friendly packaging solutions.

North America is Expected to Grow Considerably

North America is expected to hold a significant share of the nasal packaging devices market during the forecast period.

The factors attributed to such a share are the growing use of nasal packing devices to treat a rising number of epistaxis patients due to the rising nose and sinus disorders, as well as an increase in the number of market players in the region. For instance, chronic sinusitis affects nearly 31 million people in the US according to the University of Michigan Health.

Major Market Players

  • Anthony Products is a company that specializes in manufacturing and supplying medical devices, instruments, and equipment for a wider range of medical fields including otolaryngology. It deals in nasal drip pads, 30-second rhino rocket nasal packs, and more.
  • Innovia Medical, founded in 1978 is a surgical specialty company in various fields such as aesthetics, ear, nose, and throat, among others. AbsorbENT(R) Anatomical Nasal Packs are offered by the company for epistaxis management. It uses three-dimensional linked open cells that are soft and malleable.
  • Nipro, established in 1954 is a Japanese medical equipment manufacturing company. The Exadose(TM) Nasal Spray offered by the company has a novel two-step quantitative delivery method. The unique plunger design guarantees that half a dosage is administered precisely in each nasal cavity.

Key Market Developments

  • In July 2023, the FDA approved RiVive(TM) Over-the-Counter Nasal Spray developed by Harm Reduction Therapeutics for the emergency treatment of opioid overdose.
  • In November 2022, Aptar Pharma, a prominent player in the field of drug delivery and active material science solutions, has revealed a partnership with TFF Pharmaceuticals, Inc., a biopharmaceutical company in the clinical stage dedicated to the creation and distribution of innovative drug products utilizing its patented Thin Film Freezing technology platform. The collaboration is focused on the development and evaluation of dry powder vaccines administration using TFF Pharmaceutical's Thin Film Freezing technology combined with Aptar Pharma's exclusive intranasal Unidose (UDS) Powder Nasal Spray System.
  • In December 2020, Medtronic launched the Novapak Nasal Sinus Packing and Stent, a disposable and dissolvable packing specifically designed for post-sinus surgery use. It helps control bleeding, prevent adhesions, and create a moist healing environment for rapid patient recovery.

Segmentation:

By Product

  • Injectable
  • Gel
  • Spray
  • Dressings

By Type

  • Bio-Resorbable
  • Non-Absorbable

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. NASAL PACKAGING DEVICES MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Injectable
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Gel
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Spray
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Dressings
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. NASAL PACKAGING DEVICES MARKET, BY TYPE

  • 6.1. Introduction
  • 6.2. Bio-resorbable
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Non-absorbable
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. NASAL PACKAGING DEVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Clinics
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. NASAL PACKAGING DEVICES MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By End-user
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Type
    • 8.3.3. By End-user
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Type
    • 8.4.3. By End-user
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Type
    • 8.5.3. By End-user
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Type
    • 8.6.3. By End-user
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Meril Life
  • 10.2. Anthony Products
  • 10.3. Medtronic
  • 10.4. Entsho
  • 10.5. Innovia Medical
  • 10.6. Cenefom
  • 10.7. Nipro
  • 10.8. Lohmann & Rauscher
  • 10.9. Medline